71 related articles for article (PubMed ID: 27309036)
1. Role of human epidermal growth factor receptor 2 as a prognostic factor for survival in esophageal carcinoma: evidence from 2872 subjects.
Wang WJ; Wu MJ; Chang J; Xie P; Lu ZQ; Ren JL
Minerva Med; 2016 Oct; 107(5):328-41. PubMed ID: 27309036
[TBL] [Abstract][Full Text] [Related]
2. C-Met as a potential novel prognostic marker in squamous cell carcinoma and adenocarcinoma of esophagus: evidence from a meta-analysis.
Ren JL; Wu HF; Wang WJ; Hu GM; Gu B; Zhang M; Wang YX
Panminerva Med; 2017 Mar; 59(1):97-106. PubMed ID: 27636117
[TBL] [Abstract][Full Text] [Related]
3. Clinicopathological and prognostic significance of epidermal growth factor receptor overexpression in patients with esophageal adenocarcinoma: a meta-analysis.
Guo YM; Yu WW; Zhu M; Guo CY
Dis Esophagus; 2015; 28(8):750-6. PubMed ID: 24961755
[TBL] [Abstract][Full Text] [Related]
4. The correlation between high body mass index and survival in patients with esophageal cancer after curative esophagectomy: evidence from retrospective studies.
Pan W; Sun Z; Xiang Y; Fang W
Asia Pac J Clin Nutr; 2015; 24(3):480-8. PubMed ID: 26420190
[TBL] [Abstract][Full Text] [Related]
5. Prognostic Value of MicroRNAs in Esophageal Carcinoma: A Meta-Analysis.
Gao S; Zhao ZY; Zhang ZY; Zhang Y; Wu R
Clin Transl Gastroenterol; 2018 Nov; 9(11):203. PubMed ID: 30420592
[TBL] [Abstract][Full Text] [Related]
6. [HER2 expression and its prognostic implication in lymph node negative breast carcinoma: a Meta-analysis].
Guo H; Wei B; Zhang HY; Liu GJ; Bu H; Lang ZQ; Tang X; Dai QQ; Chen HJ; Zhou Y
Zhonghua Bing Li Xue Za Zhi; 2005 Mar; 34(3):140-6. PubMed ID: 15938823
[TBL] [Abstract][Full Text] [Related]
7. Prognostic Value of Perineural Invasion in Esophageal and Esophagogastric Junction Carcinoma: A Meta-Analysis.
Gao A; Wang L; Li J; Li H; Han Y; Ma X; Sun Y
Dis Markers; 2016; 2016():7340180. PubMed ID: 27051075
[TBL] [Abstract][Full Text] [Related]
8. Prognostic value of the C-reactive protein to albumin ratio in esophageal cancer: A systematic review and meta-analysis.
Wang Y; Hu X; Huang Y; Xu WY; Wu YM; Li PF; Che GW
Kaohsiung J Med Sci; 2020 Jan; 36(1):54-61. PubMed ID: 31512813
[TBL] [Abstract][Full Text] [Related]
9. Prognostic role of HER2 expression in bladder cancer: a systematic review and meta-analysis.
Zhao J; Xu W; Zhang Z; Song R; Zeng S; Sun Y; Xu C
Int Urol Nephrol; 2015 Jan; 47(1):87-94. PubMed ID: 25384433
[TBL] [Abstract][Full Text] [Related]
10. TIF1γ interferes with TGFβ1/SMAD4 signaling to promote poor outcome in operable breast cancer patients.
Kassem L; Deygas M; Fattet L; Lopez J; Goulvent T; Lavergne E; Chabaud S; Carrabin N; Chopin N; Bachelot T; Gillet G; Treilleux I; Rimokh R
BMC Cancer; 2015 Jun; 15():453. PubMed ID: 26040677
[TBL] [Abstract][Full Text] [Related]
11. Moderate HER2 expression as a prognostic factor in hormone receptor positive breast cancer.
Eggemann H; Ignatov T; Burger E; Kantelhardt EJ; Fettke F; Thomssen C; Costa SD; Ignatov A
Endocr Relat Cancer; 2015 Oct; 22(5):725-33. PubMed ID: 26187126
[TBL] [Abstract][Full Text] [Related]
12. Astrocyte Elevated Gene-1 as a Novel Clinicopathological and Prognostic Biomarker for Gastrointestinal Cancers: A Meta-Analysis with 2999 Patients.
Luo Y; Zhang X; Tan Z; Wu P; Xiang X; Dang Y; Chen G
PLoS One; 2015; 10(12):e0145659. PubMed ID: 26710214
[TBL] [Abstract][Full Text] [Related]
13. Prognostic impact of tumor length in esophageal Cancer: a systematic review and Meta-analysis.
Wang ZY; Jiang YZ; Xiao W; Xue XB; Zhang XW; Zhang L
BMC Cancer; 2021 Sep; 21(1):988. PubMed ID: 34479538
[TBL] [Abstract][Full Text] [Related]
14. Improved outcome of high-risk early HER2 positive breast cancer with high CXCL13-CXCR5 messenger RNA expression.
Razis E; Kalogeras KT; Kotoula V; Eleftheraki AG; Nikitas N; Kronenwett R; Timotheadou E; Christodoulou C; Pectasides D; Gogas H; Wirtz RM; Makatsoris T; Bafaloukos D; Aravantinos G; Televantou D; Pavlidis N; Fountzilas G
Clin Breast Cancer; 2012 Jun; 12(3):183-93. PubMed ID: 22607768
[TBL] [Abstract][Full Text] [Related]
15. Prognostic role of HER2 amplification based on fluorescence in situ hybridization (FISH) in pancreatic ductal adenocarcinoma (PDAC): a meta-analysis.
Li X; Zhao H; Gu J; Zheng L
World J Surg Oncol; 2016 Feb; 14(1):38. PubMed ID: 26897036
[TBL] [Abstract][Full Text] [Related]
16. Poor prognosis of single hormone receptor- positive breast cancer: similar outcome as triple-negative breast cancer.
Bae SY; Kim S; Lee JH; Lee HC; Lee SK; Kil WH; Kim SW; Lee JE; Nam SJ
BMC Cancer; 2015 Mar; 15():138. PubMed ID: 25880075
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of miR-21 and miR-375 as prognostic biomarkers in esophageal cancer.
Winther M; Alsner J; Tramm T; Baeksgaard L; Holtved E; Nordsmark M
Acta Oncol; 2015; 54(9):1582-91. PubMed ID: 26481465
[TBL] [Abstract][Full Text] [Related]
18. Preoperative plasma fibrinogen is associated with poor prognosis in esophageal carcinoma: a meta-analysis.
Lv GY; Yu Y; An L; Sun XD; Sun DW
Clin Transl Oncol; 2018 Jul; 20(7):853-861. PubMed ID: 29134563
[TBL] [Abstract][Full Text] [Related]
19. Expression status of fatty acid synthase (FAS) but not HER2 is correlated with the differentiation grade and prognosis of esophageal carcinoma.
Wu D; Xu J; Yu G; Zhang B; Wang H; Wang C; Ru G; Sun A; Shen L; Wei Q
Hepatogastroenterology; 2013; 60(121):99-106. PubMed ID: 23419663
[TBL] [Abstract][Full Text] [Related]
20. Dickkopf-1 expression as a marker for predicting clinical outcome in esophageal squamous cell carcinoma.
Makino T; Yamasaki M; Takemasa I; Takeno A; Nakamura Y; Miyata H; Takiguchi S; Fujiwara Y; Matsuura N; Mori M; Doki Y
Ann Surg Oncol; 2009 Jul; 16(7):2058-64. PubMed ID: 19408050
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
